VANGUARD GROUP INC - IMMIX BIOPHARMA INC ownership

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 19 filers reported holding IMMIX BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q3 2023$363,238
+28.2%
106,210
+0.8%
0.00%
Q2 2023$283,410
+47.8%
105,3570.0%0.00%
Q1 2023$191,750
-20.5%
105,3570.0%0.00%
Q4 2022$241,268
+68.7%
105,357
+0.2%
0.00%
Q3 2022$143,000
+8.3%
105,125
+106.5%
0.00%
Q2 2022$132,00050,9050.00%
Other shareholders
IMMIX BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 25,000$580.07%
Moss Adams Wealth Advisors LLC 20,000$45,8000.02%
Murchinson Ltd. 67,200$153,8880.02%
BOOTHBAY FUND MANAGEMENT, LLC 33,600$76,9440.00%
InterOcean Capital Group, LLC 15,900$36,4110.00%
TWO SIGMA SECURITIES, LLC 12,597$28,8470.00%
BANK OF AMERICA CORP /DE/ 10$220.00%
WELLS FARGO & COMPANY/MN 37$850.00%
NORTHERN TRUST CORP 19,151$43,8560.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IMMIX BIOPHARMA INC shareholders